Control of simian immunodeficiency virus replication by vaccine-induced Gag- and vif-specific CD8+ T cells

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 425-433

  Iwamoto, Nami ^a,b   Takahashi, Naofumi ^a,b   Seki, Sayuri ^a,b   Nomura, Takushi ^a,b   Yamamoto, Hiroyuki ^a   Inoue, Makoto ^c   Shu, Tsugumine ^c   Naruse, Taeko K ^d   Kimura, Akinori ^d   Matano, Tetsuro ^a,b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c DNAVEC Corporation   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; EPITOPE; GAG PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; PLACEBO; VIF PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TARGETING; EXPRESSION VECTOR; IMMUNOSTIMULATION; INFECTION CONTROL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENE PRODUCTS, GAG; GENE PRODUCTS, VIF; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84890876216     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02634-13     Document Type: Article

References (53)

1. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
2. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
3. Matano T, Shibata R, Siemon C, Connors M, Lane HC, Martin MA. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:164-169.
4. +lymphocytes. Science 283:857-860. http://dx.doi.org/10.1126/science.283.5403 .857.
5. Matano T, Kobayashi M, Igarashi H, Takeda A, Nakamura H, Kano M, Sugimoto C, Mori K, Iida A, Hirata T, Hasegawa M, Yuasa T, Miyazawa M, Takahashi Y, Yasunami M, Kimura A, O'Connor DH, Watkins DI, Nagai Y. 2004. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J. Exp. Med. 199:1709-1718. http://dx.doi.org/10.1084/jem.20040432.
6. + central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312:1530-1533. http://dx.doi.org/10.1126/science.1124226.
7. Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, Furlott J, Gonzalez EJ, Yant LJ, Maness NJ, May GE, Soma T, Reynolds MR, Rakasz E, Rudersdorf R, McDermott AB, O'Connor DH, Friedrich TC, Allison DB, Patki A, Picker LJ, Burton DR, Lin J, Huang L, Patel D, Heindecker G, Fan J, Citron M, Horton M, Wang F, Liang X, Shiver JW, Casimiro DR, Watkins DI. 2006. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol. 80:5875-5885. http://dx.doi.org/10.1128/JVI.00171-06.
8. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91. http://dx.doi .org/10.1038/nature07469.
9. Hansen SG, Ford JC, Lewis MS, Ventura AB, Hughes CM, Coyne-Johnson L, Whizin N, Oswald K, Shoemaker R, Swanson T, Legasse AW, Chiuchiolo MJ, Parks CL, Axthelm MK, Nelson JA, Jarvis MA, Piatak M, Jr, Lifson JD, Picker LJ. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473:523-527. http://dx.doi.org/10.1038/nature10003.
10. + T cells control AIDS virus replication. Nature 491:129-133. http://dx.doi.org/10.1038 /nature11443.
11. Rivière Y, McChesney MB, Porrot F, Tanneau-Salvadori F, Sansonetti P, Lopez O, Pialoux G, Feuillie V, Mollereau M, Chamaret S, Tekaia F, Montagnier L. 1995. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses 11:903-907. http://dx.doi.org/10 .1089/aid.1995.11.903.
12. +T-cell responses to the Gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76:2298-2305. http://dx.doi.org/10.1128/jvi.76.5 .2298-2305.2002.
13. Novitsky V, Gilbert P, Peter T, McLane MF, Gaolekwe S, Rybak N, Thior I, Ndung'u T, Marlink R, Lee TH, Essex M. 2003. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J. Virol. 77:882-890. http://dx.doi.org/10.1128/JVI.77.2.882-890.2003.
14. + T cells: correlation with viral load. J. Virol. 78:3233-3243. http://dx.doi.org/10.1128 /JVI.78.7.3233-3243.2004.
15. Zuñiga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, Hildebrand W, Altfeld M, Allen TM, Walker BD, Korber BT, Leitner T, Sanchez J, Brander C. 2006. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J. Virol. 80: 3122-3125. http://dx.doi.org/10.1128/JVI.80.6.3122-3125.2006.
16. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13:46-53. http://dx.doi .org/10.1038/nm1520.
17. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, Connors M. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. U. S. A. 97:2709-2714. http://dx.doi.org/10.1073 /pnas.050567397.
18. Mühl T, Krawczak M, Ten Haaft P, Hunsmann G, Sauermann U. 2002. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 169:3438-3446.
19. Tang J, Tang S, Lobashevsky E, Myracle AD, Fideli U, Aldrovandi G, Allen S, Musonda R, Kaslow RA, Zambia-UAB HIV Research Project. 2002. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J. Virol. 76:8276-8284. http://dx.doi.org/10.1128/JVI .76.16.8276-8284.2002.
20. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, Vogel M, Yu XG, Draenert R, Johnston MN, Strick D, Allen TM, Feeney ME, Kahn JO, Sekaly RP, Levy JA, Rockstroh JK, Goulder PJ, Walker BD. 2003. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17:2581-2591. http://dx.doi.org/10.1097 /00002030-200312050-00005.
21. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJ. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432:769-775. http://dx.doi.org/10.1038/nature03113.
22. Bontrop RE, Watkins DI. 2005. MHC polymorphism: AIDS susceptibility in nonhuman primates. Trends Immunol. 26:227-233. http://dx.doi .org/10.1016/j.it.2005.02.003.
23. Yant LJ, Friedrich TC, Johnson RC, May GE, Maness NJ, Enz AM, Lifson JD, O'Connor DH, Carrington M, Watkins DI. 2006. The highfrequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J. Virol. 80:5074-5077. http://dx.doi.org/10.1128/JVI.80.10 .5074-5077.2006.
24. Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM, Lifson JD, Carrington M, Watkins DI. 2007. Mamu-*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81:8827-8832. http://dx.doi.org /10.1128/JVI.00895-07.
25. + T-cell responses in SIVmac239 infection of Burmese rhesus macaques. PLoS One 8:e54300. http://dx.doi.org/10.1371/journal .pone.0054300.
26. Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothé BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O'Connor DH, Watkins DI. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat. Med. 10:275-281. http://dx.doi.org/10.1038/nm998.
27. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, Goulder PJ. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282-289. http://dx.doi.org/10.1038/nm992.
28. Feeney ME, Tang Y, Roosevelt KA, Leslie AJ, McIntosh K, Karthas N, Walker BD, Goulder PJ. 2004. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-termnonprogressing child. J. Virol. 78:8927-8930. http://dx.doi.org/10.1128 /JVI.78.16.8927-8930.2004.
29. Goulder PJR, Watkins DI. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8:619-630. http://dx.doi.org/10.1038/nri2357.
30. Goulder PJR, Watkins DI. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4:630-640. http://dx.doi.org/10 .1038/nri1417.
31. Martinez-Picado J, Prado JG, Fry EE, Pfafferott K, Leslie A, Chetty S, Thobakgale C, Honeyborne I, Crawford H, Matthews P, Pillay T, Rousseau C, Mullins JI, Brander C, Walker BD, Stuart DI, Kiepiela P, Goulder P. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80: 3617-3623. http://dx.doi.org/10.1128/JVI.80.7.3617-3623.2006.
32. Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, Kuntzen T, Tung CS, LaBute MX, Mueller SM, Harrer T, McMichael AJ, Goulder PJ, Aiken C, Brander C, Kelleher AD, Allen TM. 2007. Escape from the dominant HLAB27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J. Virol. 81:12382-12393. http://dx.doi.org/10.1128/JVI.01543-07.
33. Miura T, Brockman MA, Schneidewind A, Lobritz M, Pereyra F, Rathod A, Block BL, Brumme ZL, Brumme CJ, Baker B, Rothchild AC, Li B, Trocha A, Cutrell E, Frahm N, Brander C, Toth I, Arts EJ, Allen TM, Walker BD. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition. J. Virol. 83:2743-2755. http://dx.doi.org/10.1128/JVI.02265-08.
34. + immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J. Virol. 82:1723-1738. http://dx.doi.org/10.1128/JVI.02084-07.
35. Valentine LE, Loffredo JT, Bean AT, León EJ, MacNair CE, Beal DR, Piaskowski SM, Klimentidis YC, Lank SM, Wiseman RW, Weinfurter JT, May GE, Rakasz EG, Wilson NA, Friedrich TC, O'Connor DH, Allison DB, Watkins DI. 2009. Infection with "escaped" virus variants impairs control of simian immunodeficiency virus SIVmac239 replication in Mamu-B*08-positive macaques. J. Virol. 83:11514-11527. http://dx .doi.org/10.1128/JVI.01298-09.
36. Matano T, Kano M, Nakamura H, Takeda A, Nagai Y. 2001. Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with aDNAprime/Sendai virus vector boost regimen. J. Virol. 75:11891-11896. http://dx.doi.org/10.1128/JVI.75.23 .11891-11896.2001.
37. Kawada M, Tsukamoto T, Yamamoto H, Iwamoto N, Kurihara K, Takeda A, Moriya C, Takeuchi H, Akari H, Matano T. 2008. Gagspecific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial. J. Virol. 82:10199-10206. http://dx.doi.org/10.1128/JVI.01103-08.
38. Kawada M, Igarashi H, Takeda A, Tsukamoto T, Yamamoto H, Dohki S, Takiguchi M, Matano T. 2006. Involvement of multiple epitopespecific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. J. Virol. 80:1949-1958. http://dx.doi.org/10.1128/JVI.80.4.1949-1958.2006.
39. Nomura T, Yamamoto H, Shiino T, Takahashi N, Nakane T, Iwamoto N, Ishii H, Tsukamoto T, Kawada M, Matsuoka S, Takeda A, Terahara K, Tsunetsugu-Yokota Y, Iwata-Yoshikawa N, Hasegawa H, Sata T, Naruse TK, Kimura A, Matano T. 2012. Association of major histocompatibility complex class I haplotypes with disease progression after simian immunodeficiency virus challenge in Burmese rhesus macaques. J. Virol. 86:6481-6490. http://dx.doi.org/10.1128/JVI.07077-11.
40. Naruse TK, Chen Z, Yanagida R, Yamashita T, Saito Y, Mori K, Akari H, Yasutomi Y, Miyazawa M, Matano T, Kimura A. 2010. Diversity of MHC class I genes in Burmese-origin rhesus macaques. Immunogenetics 62:601-611. http://dx.doi.org/10.1007/s00251-010-0462-z.
41. Argüello JR, Little AM, Pay AL, Gallardo D, Rojas I, Marsh SG, Goldman JM, Madrigal JA. 1998. Mutation detection and typing of polymorphic loci through double-strand conformation analysis. Nat. Genet. 18:192-194. http://dx.doi.org/10.1038/ng0298-192.
42. + T-cell preservation after nonsterile protection by a cytotoxic T lymphocyte-based vaccine. J. Virol. 81:5202-5211. http://dx.doi.org/10.1128/JVI.02881-06.
43. Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T. 2007. Postinfection immunodeficiency virus control by neutralizing antibodies. PLoS One 2:e540. http://dx.doi.org/10.1371/journal.pone.0000540.
44. Kestler HW, III, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662. http://dx .doi.org/10.1016/0092-8674(91)90097-I.
45. Shibata R, Maldarelli F, Siemon C, Matano T, Parta M, Miller G, Fredrickson T, Martin MA. 1997. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques: determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 176:362-373. http: //dx.doi.org/10.1086/514053.
46. Takeda A, Igarashi H, Nakamura H, Kano M, Iida A, Hirata T, Hasegawa M, Nagai Y, Matano T. 2003. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replicationdefective Sendai virus vector, in a macaque AIDS model. J. Virol. 77:9710-9715. http://dx.doi.org/10.1128/JVI.77.17.9710-9715.2003.
47. Schindler M, Münch J, Brenner M, Stahl-Hennig C, Skowronski J, Kirchhoff F. 2004. Comprehensive analysis of nef functions selected in simian immunodeficiency virus-infected macaques. J. Virol. 78:10588-10597. http://dx.doi.org/10.1128/JVI.78.19.10588-10597.2004.
48. + T cell responses in macaques infected with simian immunodeficiency virus. Virology 272:347-356. http://dx.doi.org/10.1006/viro.2000.0404.
49. + cell responses in vaccinebased simian immunodeficiency virus controllers. AIDS 24:2777-2787. http://dx.doi.org/10.1097/QAD.0b013e3283402206.
50. Nakamura M, Takahara Y, Ishii H, Sakawaki H, Horiike M, Miura T, Igarashi T, Naruse TK, Kimura A, Matano T, Matsuoka S. 2011. Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses during primary simian immunodeficiency virus infection in Burmese rhesus macaques. Microbiol. Immunol. 55:768-773. http://dx.doi .org/10.1111/j.1348-0421.2011.00384.x.
51. Frahm N, Kiepiela P, Adams S, Linde CH, Hewitt HS, Sango K, Feeney ME, Addo MM, Lichterfeld M, Lahaie MP, Pae E, Wurcel AG, Roach T, St. John MA, Altfeld M, Marincola FM, Moore C, Mallal S, Carrington M, Heckerman D, Allen TM, Mullins JI, Korber BT, Goulder PJ, Walker BD, Brander C. 2006. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat. Immunol. 7:173-178. http://dx.doi.org/10.1038/ni1281.
52. + T-cell responses are involved in durable control of AIDS virus replication. J. Virol. 81:3465-3476. http://dx.doi.org/10.1128 /JVI.02392-06.
53. + T lymphocyte responses predict HIV-1 disease progression. J. Virol. 86:10505-10516. http: //dx.doi.org/10.1128/JVI.00102-12.